5442642025-01-012025-03-315442642025-03-315442642024-03-315442642024-04-012025-03-315442642025-01-012025-03-31in-capmkt:OtherExpenses1Member5442642025-01-012025-03-31in-capmkt:OtherExpenses2Member5442642024-04-012025-03-31in-capmkt:OtherExpenses1Member5442642024-04-012025-03-31in-capmkt:OtherExpenses2Member5442642025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15442642025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25442642025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35442642024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15442642024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25442642024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35442642025-01-012025-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544264DIFFNKGNOTLISTEDINE184O01015DIFFUSION ENGINEERS LIMITEDMain BoardEquity2024-04-012025-03-312025-05-15INRMillionsQuarterlyFourth quarterSingle segmentWelding Fabrication Technology and Engineering2025-05-1515:10:002025-05-1518:18:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated10244800005036000010748400004916200003060000525700001102700003990000131300002199500008945900001802500000180250000473800002640000500200000130230000000-120000130110000-760000129350000374260000374.263.493.49003.493.490.00060.29371.The equity shares of the Company have been listed on National Stock Exchange of India Limited and on BSE Limited on October 4 2024 by completing Initial Public Offer of 9355000 equity shares of face value of Rs 10 each at an issue price of Rs. 168 per equity share aggregating to Rs. 1571.64 million and 50,000 equity shares to employees of face value of Rs. 10 each and an issue price of Rs. 160 per equity shares including share premium of Rs. 150 per equity share aggregating to Rs. 8 million. Total amount aggregating to Rs. 1579.64 million. <BR> <BR> 2.These audited financial results have been prepared in accordance with Indian Accounting Standards Ind AS prescribed under Section 133 of the Companies Act.2013 and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015. <BR> <BR> 3.The above audited consolidated financial results for the quarter ended 31st March 2025 and for the year ended 31st March 2025 in respect of Diffusion Engineers Limited have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on 14th May 2025 and 15th May 2025 respectively. The Statutory auditors have expressed unmodified opinion on financial results for the quarter ended 31st March 2025 and for the year ended 31st March 2025 <BR> <BR> 4.The Audited Financial Results for the quarter ended March 31, 2025 is the balancing figures between audited figures in respect of the full financial year and the audited year to date figures of the third quarter of the respective period ended 31St December, 2024. <BR> <BR> March 31, 2024 extracted from the audited Financials Statement of that period. <BR> <BR> 5.As a result of the Management review mechanism, the Company has one segment Welding Fabrication Technology and Engineering which includes Manufacturing Trading and Job Work. <BR> 6.Dividends Paid by Diffusion Wear Solutions Philippines Inc. have been recognized as income in Diffusion Engineers Singapore Pte Ltd's standalone financial statements for FY 2024–2025. However in the consolidated financial statements the dividend received from group company are eliminated as intercompany transactions do not impact the group’s consolidated profit. <BR> <BR> 7.The Board of Directors has recommended dividend of 15%, subject to the approval of shareholder scheme. <BR> <BR> 8.The figures of previous periods year are reclassified regrouped and rearranged wherever necessary so as to make them comparable with current period's figures. <BR> 2024-04-012025-03-31AuditedConsolidated33519600009327000034452300001655230000211610000-10721000041902000022740000527500007025400002956680000488550000048855000010513000035000001086300000379920000000-19510000360410000510000360920000374260000374.2633145100009.599.59009.599.590.00060.2937Manufacturing expenses147060000Other expenses72890000Manufacturing expenses468930000Other expenses23361000097400000031440000004830000000346010000009046000043647000014467400006827300000848010000127054000001175500001068000022467800006817000029976800004444420000374260000331451000036887700004460000369323000001028000010280000055940000662200002321400002883000025608000028491000089900005260400001374400002149000068497000075119000044444200000-150610000-1802400000-310900000000-3721000004269000005275000001284000000019000000420100000740000000071200000-3164600001720900000-2274000001086300000862000000008098000000000148850000000580000000000074500000000004201000000-18095000000143808000000000-112210000001596000022740000001287170000119242000001192420000781300001270550000Remeasurements of the defined benefit plans-3410000Income tax effect on above750000Foreign currency translation of foreign operations1900000-760000Remeasurements of the defined benefit plans-1800000Income tax effect on above410000Foreign currency translation of foreign operations190000051000000-760000510000AuditedtrueM/S PGS and associatestrue2027-08-31